Ruxolitinib in Combination with Vorinostat Suppresses Tumor Growth and Alters the Metabolic Phenotype in Haematological Diseases

被引:0
|
作者
Civallero, Monica
Cosenza, Maria
Marmiroli, Sandra
Pozzi, Samantha
Sacchi, Stefano
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5194
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma
    Harada, Koji
    Ferdous, Tarannum
    Harada, Toyoko
    Ueyama, Yoshiya
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (01) : 276 - 284
  • [32] The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo
    Tian, Yaomei
    Li, Meng
    Yu, Chaoheng
    Zhang, Rui
    Zhang, Xueyan
    Huang, Rong
    Lu, Lian
    Yuan, Fengjiao
    Fan, Yingzi
    Zhou, Bailing
    Men, Ke
    Xu, Heng
    Yang, Li
    ONCOTARGET, 2017, 8 (28) : 45951 - 45964
  • [33] A combination of chimeric switch-receptor T cells targeting both PD1 and CTLA4 suppresses tumor growth
    Li, Peng
    Qin, Le
    Wei, Xinru
    Zhao, Ruocong
    Lai, Yunxin
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Alpha-carotene inhibits metastasis in Lewis lung carcinoma in vitro, and suppresses lung metastasis and tumor growth in combination with taxol in tumor xenografted C57BL/6 mice
    Liu, Yi-Zhen
    Yang, Chih-Min
    Chen, Jen-Yin
    Liao, Junn-Wang
    Hu, Miao-Lin
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2015, 26 (06): : 607 - 615
  • [35] CpG-ODNs in combination with IFN-alpha-expressing tumor cells enhance DC maturation and the DC vaccination effectively suppresses the growth of the established tumors
    Hiraide, Ayako
    Doi, Hiroyoshi
    Ishii, Shigeaki
    Eguchi, Junichi
    Hiroishi, Kazumasa
    Imawari, Michio
    CANCER RESEARCH, 2006, 66 (08)
  • [36] Combination of metformin plus orlistat prevents tumor progression: novel role of the metabolic hormone fibroblast growth factor 21 (FGF21)
    Sivaram, Shobika
    Baljinnyam, Erdene
    Iwatsubo, Kousaku
    Puricelli, Lydia I.
    De Lorenzo, Mariana S.
    CANCER RESEARCH, 2014, 74 (19)
  • [37] Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
    Elgendy, Mohamed
    Ciro, Marco
    Hosseini, Amir
    Weiszmann, Jakob
    Mazzarella, Luca
    Ferrari, Elisa
    Cazzoli, Riccardo
    Curigliano, Giuseppe
    DeCensi, Andrea
    Bonanni, Bernardo
    Budillon, Alfredo
    Pelicci, Pier Giuseppe
    Janssens, Veerle
    Ogris, Manfred
    Baccarini, Manuela
    Lanfrancone, Luisa
    Weckwerth, Wolfram
    Foiani, Marco
    Minucci, Saverio
    CANCER CELL, 2019, 35 (05) : 798 - +
  • [38] Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence
    Beni Lestari
    Ikuko Nakamae
    Noriko Yoneda-Kato
    Tsumoru Morimoto
    Shigehiko Kanaya
    Takashi Yokoyama
    Masafumi Shionyu
    Tsuyoshi Shirai
    Edy Meiyanto
    Jun-ya Kato
    Scientific Reports, 9
  • [39] Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence
    Lestari, Beni
    Nakamae, Ikuko
    Yoneda-Kato, Noriko
    Morimoto, Tsumoru
    Kanaya, Shigehiko
    Yokoyama, Takashi
    Shionyu, Masafumi
    Shirai, Tsuyoshi
    Meiyanto, Edy
    Kato, Jun-ya
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production
    Yin, Kunlun
    Lee, Jordan
    Liu, Zhaoli
    Kim, Hyeoncheol
    Martin, David R.
    Wu, Dandan
    Liu, Meilian
    Xue, Xiang
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (08): : 2421 - 2435